Inactive Instrument

Insiders KARA THER

Equities

Karuna Therapeutics, Inc. and Miramar Merger Sub Inc. Announce Management Changes	Mar. 18	CI
Karuna Therapeutics, Inc. Announces Resignation of Steve Paul as Chief Scientific Officer and President of Research and Development	Jan. 16	CI
Karuna Therapeutics Insider Sold Shares Worth $4,752,150, According to a Recent SEC Filing	Jan. 09	MT
Karuna Therapeutics Insider Sold Shares Worth $2,023,676, According to a Recent SEC Filing	Dec. 12	MT
Karuna Therapeutics Insider Sold Shares Worth $889,260, According to a Recent SEC Filing	Nov. 13	MT
Karuna Therapeutics Insider Sold Shares Worth $866,213, According to a Recent SEC Filing	23-10-10	MT
Insider Sell: Karuna Therapeutics	23-08-10	MT
Karuna Therapeutics Q2 Net Loss Widens; Expects Cash Runway Through 2026	23-08-03	MT
Karuna Therapeutics, Inc. Announces Appointment of Jonathan Rosin to Chief Human Resources Officer	23-08-03	CI
Insider Sell: Karuna Therapeutics	23-08-02	MT
Abivax: two appointments to the Board of Directors	23-07-12	CF
Insider Sell: Karuna Therapeutics	23-07-05	MT
Insider Sell: Karuna Therapeutics	23-07-05	MT
Insider Sell: Karuna Therapeutics	23-05-25	MT
Insider Sell: Karuna Therapeutics	23-04-21	MT
Insider Sell: Karuna Therapeutics	23-04-12	MT
Insider Sell: Karuna Therapeutics	23-03-09	MT
Insider Sell: Karuna Therapeutics	23-02-23	MT
Insider Sell: Karuna Therapeutics	23-02-13	MT
BioXcel Executive Joins Karuna Therapeutics as Chief Commercial Officer	23-01-31	MT

No results for this search